MICOTEF SOL VAG 5FL 150ML 0.2%

MICOTEF 0.2% VAGINAL DEPARTMENT

active ingredients

100 ml of vaginal solution contain: Active ingredient: miconazole 0.200 g. Excipients: propilenglycole. For the full list of excipients, see paragraph 6.1.

Excellent

Propilenglycol, lactic acid, undebenzofene, ricinoleilic alcohol, polysorbate 20, fragrant composition, purified water.

Therapeutic indications

Adjuvant of vulvo–vaginal affection therapy from Candida, although superinfected by Gram-positive germs: can also be used after other topical therapy or os, in order to reduce the risk of relapse.

Contraindications

Hypersensitivity to the active ingredient or any of the excipients.

Population

In the morning apply the solution in the vagina using the whole bottle. Daily applications can extend to doctor's judgment, over the normal 5 – 6 days of therapy.

Conservation

Store at a temperature not exceeding 25° C.

Warnings

Perform the following: 1) hold the bottle for the zigrinate ring and rotate the cap, until breaking the safety seal and tighten it until touching the head of the cannula below; 2) extract the cannula always keeping it through the hood, until its stop, continue to pull the head until you notice the click of the right positioning; N.B. Only the complete sliding of the head of the cannula allows the correct exit of the solution. 3) introduce the cannula in the vagina gently and press the walls of the bottle with more or less intense pressure, so as to realize the complete emptying; a special valve does not allow the return of the solution in the bottle. Irrigation should be carried out preferably in a relaxed position. Slow irrigation promotes better medical detersion. Micotef 0.2% vaginal solution is easy to apply, does not spot skin or clothing. Keep out of the reach of children. This medicine contains propylenglycol between excipients and therefore can cause skin irritation

Interactions

No checks.

Effects

Miconazole therapy is well tolerated. Rarely miconazole can cause burning or vaginal irritation, pelvic cramps; more rarely skin rashes and cephales. In these cases it is necessary to suspend treatment and establish suitable therapy.

Overdosing

Nothing to report.

In the first trimester of pregnancy, the product must be used only in case of actual need and under direct medical control.

Source: Farmadati